126 related articles for article (PubMed ID: 22156608)
1. Curcumins promote monocytic gene expression related to β-amyloid and superoxide dismutase clearance.
Cashman JR; Gagliardi S; Lanier M; Ghirmai S; Abel KJ; Fiala M
Neurodegener Dis; 2012; 10(1-4):274-6. PubMed ID: 22156608
[TBL] [Abstract][Full Text] [Related]
2. Evaluation in vitro of synthetic curcumins as agents promoting monocytic gene expression related to β-amyloid clearance.
Gagliardi S; Ghirmai S; Abel KJ; Lanier M; Gardai SJ; Lee C; Cashman JR
Chem Res Toxicol; 2012 Jan; 25(1):101-12. PubMed ID: 22029407
[TBL] [Abstract][Full Text] [Related]
3. Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin.
Fiala M; Liu PT; Espinosa-Jeffrey A; Rosenthal MJ; Bernard G; Ringman JM; Sayre J; Zhang L; Zaghi J; Dejbakhsh S; Chiang B; Hui J; Mahanian M; Baghaee A; Hong P; Cashman J
Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12849-54. PubMed ID: 17652175
[TBL] [Abstract][Full Text] [Related]
4. 1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients.
Masoumi A; Goldenson B; Ghirmai S; Avagyan H; Zaghi J; Abel K; Zheng X; Espinosa-Jeffrey A; Mahanian M; Liu PT; Hewison M; Mizwickie M; Cashman J; Fiala M
J Alzheimers Dis; 2009; 17(3):703-17. PubMed ID: 19433889
[TBL] [Abstract][Full Text] [Related]
5. Immune defects in Alzheimer's disease: new medications development.
Cashman JR; Ghirmai S; Abel KJ; Fiala M
BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S13. PubMed ID: 19090986
[TBL] [Abstract][Full Text] [Related]
6. 1α,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-β phagocytosis and inflammation in Alzheimer's disease patients.
Mizwicki MT; Liu G; Fiala M; Magpantay L; Sayre J; Siani A; Mahanian M; Weitzman R; Hayden EY; Rosenthal MJ; Nemere I; Ringman J; Teplow DB
J Alzheimers Dis; 2013; 34(1):155-70. PubMed ID: 23186989
[TBL] [Abstract][Full Text] [Related]
7. Delineating Alzheimer's disease progression with MGAT3, a biomarker for improved prognosis and personalized therapy.
Fiala M; Porter V
Biomark Med; 2011 Oct; 5(5):645-7. PubMed ID: 22003913
[No Abstract] [Full Text] [Related]
8. MGAT3 mRNA: a biomarker for prognosis and therapy of Alzheimer's disease by vitamin D and curcuminoids.
Fiala M; Mahanian M; Rosenthal M; Mizwicki MT; Tse E; Cho T; Sayre J; Weitzman R; Porter V
J Alzheimers Dis; 2011; 25(1):135-44. PubMed ID: 21368380
[TBL] [Abstract][Full Text] [Related]
9. Curcumin and Novel Synthetic Analogs in Cell-Based Studies of Alzheimer's Disease.
Gagliardi S; Franco V; Sorrentino S; Zucca S; Pandini C; Rota P; Bernuzzi S; Costa A; Sinforiani E; Pansarasa O; Cashman JR; Cereda C
Front Pharmacol; 2018; 9():1404. PubMed ID: 30559668
[TBL] [Abstract][Full Text] [Related]
10. Brain beta-amyloid accumulation in transgenic mice expressing mutant superoxide dismutase 1.
Turner BJ; Li QX; Laughton KM; Masters CL; Lopes EC; Atkin JD; Cheema SS
Neurochem Res; 2004 Dec; 29(12):2281-6. PubMed ID: 15672551
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol mitigates lipopolysaccharide- and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade.
Capiralla H; Vingtdeux V; Zhao H; Sankowski R; Al-Abed Y; Davies P; Marambaud P
J Neurochem; 2012 Feb; 120(3):461-72. PubMed ID: 22118570
[TBL] [Abstract][Full Text] [Related]
12. A complex proinflammatory role for peripheral monocytes in Alzheimer's disease.
Saresella M; Marventano I; Calabrese E; Piancone F; Rainone V; Gatti A; Alberoni M; Nemni R; Clerici M
J Alzheimers Dis; 2014; 38(2):403-13. PubMed ID: 23979026
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of cathepsin D in monocytes is related to the defective degradation of amyloid-β in Alzheimer's disease.
Tian L; Zhang K; Tian ZY; Wang T; Shang DS; Li B; Liu DX; Fang WG; Wang ZY; Chen YH
J Alzheimers Dis; 2014; 42(2):511-20. PubMed ID: 24898658
[TBL] [Abstract][Full Text] [Related]
14. Intravenous infusion of monocytes isolated from 2-week-old mice enhances clearance of Beta-amyloid plaques in an Alzheimer mouse model.
Hohsfield LA; Humpel C
PLoS One; 2015; 10(4):e0121930. PubMed ID: 25830951
[TBL] [Abstract][Full Text] [Related]
15. TREM1 facilitates microglial phagocytosis of amyloid beta.
Jiang T; Zhang YD; Gao Q; Zhou JS; Zhu XC; Lu H; Shi JQ; Tan L; Chen Q; Yu JT
Acta Neuropathol; 2016 Nov; 132(5):667-683. PubMed ID: 27670763
[TBL] [Abstract][Full Text] [Related]
16. Selective acetyl- and butyrylcholinesterase inhibitors reduce amyloid-β ex vivo activation of peripheral chemo-cytokines from Alzheimer's disease subjects: exploring the cholinergic anti-inflammatory pathway.
Reale M; Di Nicola M; Velluto L; D'Angelo C; Costantini E; Lahiri DK; Kamal MA; Yu QS; Greig NH
Curr Alzheimer Res; 2014; 11(6):608-22. PubMed ID: 24359497
[TBL] [Abstract][Full Text] [Related]
17. Re-balancing of inflammation and abeta immunity as a therapeutic for Alzheimer's disease-view from the bedside.
Fiala M
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):192-6. PubMed ID: 20205641
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E Polymorphism and Oxidative Stress in Peripheral Blood-Derived Macrophage-Mediated Amyloid-Beta Phagocytosis in Alzheimer's Disease Patients.
Jairani PS; Aswathy PM; Krishnan D; Menon RN; Verghese J; Mathuranath PS; Gopala S
Cell Mol Neurobiol; 2019 Apr; 39(3):355-369. PubMed ID: 30694418
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory effects of different curcuminoids on β-amyloid protein, β-amyloid precursor protein and β-site amyloid precursor protein cleaving enzyme 1 in swAPP HEK293 cells.
Liu H; Li Z; Qiu D; Gu Q; Lei Q; Mao L
Neurosci Lett; 2010 Nov; 485(2):83-8. PubMed ID: 20727383
[TBL] [Abstract][Full Text] [Related]
20. The anti-inflammatory Annexin A1 induces the clearance and degradation of the amyloid-β peptide.
Ries M; Loiola R; Shah UN; Gentleman SM; Solito E; Sastre M
J Neuroinflammation; 2016 Sep; 13(1):234. PubMed ID: 27590054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
